Real-time enrollment status for this type 1 diabetes clinical trial
Current Status
Active, Not Recruiting
Checked: September 1, 2026 at 3:50 PM UTC
| NCT Number | NCT07076199 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Type 1 Diabetes |
| Phase | PHASE3 |
| Target Enrollment | 877 participants |
| Active Locations | 114 sites in the US |
| Sponsor | Novo Nordisk A/S |
| Last Updated on CT.gov | September 1, 2026 (15 hours ago) |
As of September 1, 2026: Clinical trial NCT07076199 is currently active_not_recruiting participants. This phase3 study for type 1 diabetes is not currently accepting new participants at 114 locations across the United States. The study is sponsored by Novo Nordisk A/S. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07076199 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 114 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07076199 was last updated 15 hours ago (September 1, 2026). HelloStudys verifies this status automatically.